V009-1912 Screening compound: 4-(3-chloro-4-fluorophenyl)-2-(4-methoxyphenyl)-N6-(propan-2-yl)-2H-pyrazolo[3,4-d]pyrimidine-3,6-diamine

V009-1912 Screening compound: 4-(3-chloro-4-fluorophenyl)-2-(4-methoxyphenyl)-N6-(propan-2-yl)-2H-pyrazolo[3,4-d]pyrimidine-3,6-diamine
V009-1912 Screening compound: 4-(3-chloro-4-fluorophenyl)-2-(4-methoxyphenyl)-N6-(propan-2-yl)-2H-pyrazolo[3,4-d]pyrimidine-3,6-diamine alternative view

Chemical Structure Depiction of ChemDiv screening compound V009-1912
4-(3-chloro-4-fluorophenyl)-2-(4-methoxyphenyl)-N6-(propan-2-yl)-2H-pyrazolo[3,4-d]pyrimidine-3,6-diamine

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

V009-1912

Molecular Formula

C21H20ClFN6O (C21 H20 ClFN6 O)

Compound Name

4-(3-chloro-4-fluorophenyl)-2-(4-methoxyphenyl)-N6-(propan-2-yl)-2H-pyrazolo[3,4-d]pyrimidine-3,6-diamine

IUPAC name

4-(3-chloro-4-fluorophenyl)-2-(4-methoxyphenyl)-N6-(propan-2-yl)-2H-pyrazolo[34-d]pyrimidine-36-diamine

SMILES

CC(C)Nc(nc(c1c2N)-c(cc3)cc(Cl)c3F)nc1nn2-c(cc1)ccc1OC

InChI

InChI=1S/C21H20ClFN6O/c1-11(2)25-21-26-18(12-4-9-16(23)15(22)10-12)17-19(24)29(28-20(17)27-21)13-5-7-14(30-3)8-6-13/h4-11H,24H2,1-3H3,(H,25,27,28)

InChI Key

IZYAAXBQVWUZKY-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD14250019

Chemical and Physical Properties

Saltdata

not_available

Molecular Weight

426.88

Hydrogen Bond Acceptors Count

4.00

Hydrogen Bond Donors Count

3.00

Rotatable Bond Count

5.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

4.787

Distribution Coefficient, logD

4.779

Water Solubility, LogSw

-5.10

Polar Surface Area

71.600

Acid Dissociation Constant (pKa)

16.91

Base Dissociation Constant (pKb)

5.68

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

19.00

V009-1912 in Drug Discovery

Included in Screening Libraries

ACE2 Library (3043 compounds)

Anticancer Library (62698 compounds)

CORONAVIRUS Library (20774 compounds)

Adenosine Receptors Targeted Library (19896 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Antiviral
  • Infections
  • Immune system
  • Cancer
  • Antiviral
  • Infections
  • Immune system
  • Cancer
  • Digestive system
  • Respiratory tract
  • Nervous system
  • Eye
  • Cardiovascular
Targets:
  • GPCR
Mechanism of action:
  • Receptor's ligands

References: we are preparing a list of scientific research reports with V009-1912 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound V009-1912?
Check Price and Availability of V009-1912, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of V009-1912 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for V009-1912
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for V009-1912
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of V009-1912 available by request